Cite
HARVARD Citation
Guillamat-prats, R. et al. (2018). Pharmacological inhibition of monoacylglycerol lipase enhances IGM plasma levels and limits atherogenesis in a CB2-dependent manner. Atherosclerosis. pp. e45-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guillamat-prats, R. et al. (2018). Pharmacological inhibition of monoacylglycerol lipase enhances IGM plasma levels and limits atherogenesis in a CB2-dependent manner. Atherosclerosis. pp. e45-. [Online].